Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | GARP CAR-T cells |
| Synonyms | |
| Therapy Description |
GARP CAR-T cells are T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting LRRC32 (GARP), which potentially induce killing of GARP-expressing tumor cells (NCI Thesaurus). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| GARP CAR-T cells | Anti-GARP CAR-T cells | GARP CAR-T cells are T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting LRRC32 (GARP), which potentially induce killing of GARP-expressing tumor cells (NCI Thesaurus). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06964737 | Phase I | GARP CAR-T cells | Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas | Recruiting | USA | 0 |